99.809% purity — independently analysed

Sulan Bio Tirzepatide batch SN-TIRZ-B2601 was independently analysed by Janoshik Laboratory under task #105537.

The analytical report recorded 99.809% purity and 31.33 mg measured content for the submitted sample, providing batch-specific analytical documentation for this marketplace listing.

What is Tirzepatide?

Tirzepatide is a synthetic peptide that acts as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors.

Because it interacts with two incretin-related signalling pathways, Tirzepatide is widely studied in metabolic research involving glucose regulation, insulin signalling, nutrient response and energy balance.

Common research areas

Tirzepatide is commonly investigated in laboratory and metabolic research examining:

• GIP and GLP-1 receptor signalling
• Glucose homeostasis and metabolic regulation
• Insulin-response pathways
• Appetite and satiety signalling
• Energy intake and energy-balance mechanisms
• Body-weight regulation pathways
• Lipid and nutrient metabolism
• Incretin-based metabolic signalling

Available configurations

• 10mg: 10 vials per box
• 20mg: 10 vials per box
• 30mg: 10 vials per box
• MOQ: 10 vials / 1 box
• Format: Lyophilized research compound
• Supplier: Sulan Bio

Batch verification

• Supplier: Sulan Bio
• Batch: SN-TIRZ-B2601
• Reported purity: 99.809%
• Measured content: 31.33 mg
• Independent laboratory: Janoshik
• Task number: #105537
• Tested: 05 FEB 2026
• COA status: Available